These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 12476796

  • 1. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
    Lefebvre P.
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):153-64. PubMed ID: 12476796
    [Abstract] [Full Text] [Related]

  • 2. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
    Muccio DD, Brouillette WJ, Alam M, Vaezi MF, Sani BP, Venepally P, Reddy L, Li E, Norris AW, Simpson-Herren L, Hill DL.
    J Med Chem; 1996 Sep 13; 39(19):3625-35. PubMed ID: 8809153
    [Abstract] [Full Text] [Related]

  • 3. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
    Ahuja HS, Szanto A, Nagy L, Davies PJ.
    J Biol Regul Homeost Agents; 2003 Sep 13; 17(1):29-45. PubMed ID: 12757020
    [Abstract] [Full Text] [Related]

  • 4. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF, Rochel N, Birck C, Vachette P, Timmins PA, Moras D.
    J Mol Biol; 2001 Mar 23; 307(2):557-76. PubMed ID: 11254382
    [Abstract] [Full Text] [Related]

  • 5. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR, Bourguet W, Altucci L, Gronemeyer H.
    Nat Rev Drug Discov; 2007 Oct 23; 6(10):811-20. PubMed ID: 17906643
    [Abstract] [Full Text] [Related]

  • 6. Corepressor interaction differentiates the permissive and non-permissive retinoid X receptor heterodimers.
    Lammi J, Perlmann T, Aarnisalo P.
    Arch Biochem Biophys; 2008 Apr 15; 472(2):105-14. PubMed ID: 18282463
    [Abstract] [Full Text] [Related]

  • 7. The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification.
    Pijnappel WW, Hendriks HF, Folkers GE, van den Brink CE, Dekker EJ, Edelenbosch C, van der Saag PT, Durston AJ.
    Nature; 1993 Nov 25; 366(6453):340-4. PubMed ID: 8247127
    [Abstract] [Full Text] [Related]

  • 8. RAR and RXR modulation in cancer and metabolic disease.
    Altucci L, Leibowitz MD, Ogilvie KM, de Lera AR, Gronemeyer H.
    Nat Rev Drug Discov; 2007 Oct 25; 6(10):793-810. PubMed ID: 17906642
    [Abstract] [Full Text] [Related]

  • 9. Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids.
    Toma S, Isnardi L, Riccardi L, Bollag W.
    Anticancer Res; 1998 Oct 25; 18(2A):935-42. PubMed ID: 9615744
    [Abstract] [Full Text] [Related]

  • 10. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation.
    Fanjul A, Dawson MI, Hobbs PD, Jong L, Cameron JF, Harlev E, Graupner G, Lu XP, Pfahl M.
    Nature; 1994 Nov 03; 372(6501):107-11. PubMed ID: 7969403
    [Abstract] [Full Text] [Related]

  • 11. Nuclear retinoid receptors and the transcription of retinoid-target genes.
    Bastien J, Rochette-Egly C.
    Gene; 2004 Mar 17; 328():1-16. PubMed ID: 15019979
    [Abstract] [Full Text] [Related]

  • 12. Utilization of DR1 as true RARE in regulating the Ssm, a novel retinoic acid-target gene in the mouse testis.
    Han K, Song H, Moon I, Augustin R, Moley K, Rogers M, Lim H.
    J Endocrinol; 2007 Mar 17; 192(3):539-51. PubMed ID: 17332523
    [Abstract] [Full Text] [Related]

  • 13. Regulation of lipid and lipoprotein metabolism by retinoids.
    Staels B.
    J Am Acad Dermatol; 2001 Nov 17; 45(5):S158-67. PubMed ID: 11606948
    [Abstract] [Full Text] [Related]

  • 14. A decade of molecular biology of retinoic acid receptors.
    Chambon P.
    FASEB J; 1996 Jul 17; 10(9):940-54. PubMed ID: 8801176
    [Abstract] [Full Text] [Related]

  • 15. Action mechanism of retinoid-synergistic dibenzodiazepines.
    Umemiya H, Kagechika H, Fukasawa H, Kawachi E, Ebisawa M, Hashimoto Y, Eisenmann G, Erb C, Pornon A, Chambon P, Gronemeyer H, Shudo K.
    Biochem Biophys Res Commun; 1997 Apr 07; 233(1):121-5. PubMed ID: 9144408
    [Abstract] [Full Text] [Related]

  • 16. Transcriptional activities of retinoic acid receptors.
    Lefebvre P, Martin PJ, Flajollet S, Dedieu S, Billaut X, Lefebvre B.
    Vitam Horm; 2005 Apr 07; 70():199-264. PubMed ID: 15727806
    [Abstract] [Full Text] [Related]

  • 17. RXR: from partnership to leadership in metabolic regulations.
    Desvergne B.
    Vitam Horm; 2007 Apr 07; 75():1-32. PubMed ID: 17368310
    [Abstract] [Full Text] [Related]

  • 18. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.
    de Vos S, Dawson MI, Holden S, Le T, Wang A, Cho SK, Chen DL, Koeffler HP.
    Prostate; 1997 Jul 01; 32(2):115-21. PubMed ID: 9215399
    [Abstract] [Full Text] [Related]

  • 19. Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization.
    Jiang SY, Shen SR, Shyu RY, Yu JC, Harn HJ, Yeh MY, Lee MM, Chang YC.
    Br J Cancer; 1999 Apr 01; 80(1-2):206-14. PubMed ID: 10389997
    [Abstract] [Full Text] [Related]

  • 20. Characterization of synthetic retinoids with selectivity for retinoic acid or retinoid X nuclear receptors.
    LeMotte PK, Keidel S, Apfel CM.
    Biochim Biophys Acta; 1996 Mar 15; 1289(2):298-304. PubMed ID: 8600988
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.